| Literature DB >> 31599139 |
Sooyeon Lim1, Na Young Lee1, Seung Beom Han1,2, Dae Chul Jeong1,2, Jin Han Kang1,2.
Abstract
OBJECTIVES: Deep neck infections (DNIs) can cause life-threatening complications, and prompt diagnosis and management are necessary. Kawasaki disease (KD) may be accompanied by deep neck inflammation; making it difficult to distinguish from DNIs. This study was performed to evaluate clinical features and outcomes of children with parapharyngeal and retropharyngeal inflammation.Entities:
Keywords: Child; Kawasaki Disease; Korea; Retropharyngeal Abscess
Year: 2019 PMID: 31599139 PMCID: PMC7010501 DOI: 10.21053/ceo.2019.00948
Source DB: PubMed Journal: Clin Exp Otorhinolaryngol ISSN: 1976-8710 Impact factor: 3.372
Type and location of deep neck inflammation
| Factor | Number |
|---|---|
| Parapharyngeal abscess+retropharyngeal abscess | 4 |
| Parapharyngeal abscess+retropharyngeal cellulitis | 9 |
| Retropharyngeal abscess | 3 |
| Parapharyngeal cellulitis+retropharyngeal cellulitis | 5 |
| Retropharyngeal cellulitis | 26 |
Comparison between children in the DNI and KD groups
| Factor | DNI group (n=36) | KD group (n=11) | |
|---|---|---|---|
| Male sex | 21 (58.3) | 9 (81.8) | 0.282 |
| Age (yr) | 4 (0–11) | 4 (0–6) | 0.683 |
| Symptom | |||
| Fever | 32 (88.9) | 11 (100.0) | 0.560 |
| Cough | 9 (25.0) | 2 (18.2) | 1.000 |
| Rhinorrhea | 10 (27.8) | 2 (18.2) | 0.703 |
| Sputum | 4 (11.1) | 1 (9.1) | 1.000 |
| Sore throat | 15 (41.7) | 3 (27.3) | 0.492 |
| Neck pain | 16 (44.4) | 4 (36.4) | 0.737 |
| Limited neck motion | 17 (47.2) | 5 (45.5) | 1.000 |
| Trismus | 3 (8.3) | 1 (9.1) | 1.000 |
| Dysphagia | 9 (25.0) | 1 (9.1) | 0.413 |
| Sign | |||
| Pharyngeal injection | 15 (41.7) | 5 (45.5) | 1.000 |
| Tonsillar injection | 10 (27.8) | 5 (45.5) | 0.292 |
| Palpable cervical lymphadenopathy | 24 (66.7) | 11 (100.0) | 0.044 |
| Tonsillar deviation | 2 (5.6) | 0 | 1.000 |
| Fever duration (day) | |||
| Before admission | 2 (0–5) | 2 (0–5) | 0.719 |
| After admission | 2 (0–5) | 4 (2–6) | <0.001 |
| As a whole | 5 (0–7) | 6 (3–9) | <0.001 |
| Fever duration after admission (day) | 0.009 | ||
| <3 | 27 (75.0) | 3 (27.3) | |
| ≥3 | 9 (25.0) | 8 (72.7) | |
| Computed tomography finding | 0.009 | ||
| Cellulitis | 29 (80.6) | 11 (100.0) | |
| Parapharyngeal cellulitis | 4 (11.1) | 1 (9.1) | |
| Retropharyngeal cellulitis | 29 (80.6) | 11 (100.0) | |
| Abscess | 16 (44.4) | 0 | |
| Parapharyngeal abscess | 13 (36.1) | 0 | |
| Retropharyngeal abscess | 7 (19.4) | 0 | |
| White blood cell count (cells/mm3) | 16,940 (5,850–42,530) | 15,680 (4,590–22,750) | 0.123 |
| Absolute neutrophil count | 12,504 (410–36,236) | 12,632 (193–19,929) | 0.511 |
| Absolute monocyte count | 1,323 (501–3,252) | 1,067 (409–2,078) | 0.236 |
| Hemoglobin (g/dL) | 11.8 (10.4–14.1) | 11.8 (10.8–12.5) | 0.326 |
| Platelet count (cells/mm3) | 342,500 (179,000–619,000) | 308,000 (188,000–594,000) | 0.302 |
| Aspartate transaminase (IU/L) | 26 (16–52) | 26 (23–80) | 0.190 |
| Alanine transaminase (IU/L) | 14 (7–46) | 13 (9–69) | 0.543 |
| Lactate dehydrogenase (IU/L)[ | 538 (369–793) | 538 (448–877) | 0.576 |
| Erythrocyte sedimentation rate (mm/hr) | 60 (2–120) | 67 (14–105) | 0.979 |
| C-reactive protein (mg/dL) | 9.68 (0.02–21.76) | 9.73 (0.82–19.88) | 0.445 |
Values are presented as number (%) or median (range).
DNI, deep neck infection; KD, Kawasaki disease.
One child in the DNI group was not tested for lactate dehydrogenase.
Fig. 1.Neck computed tomography findings of the enrolled children. (A, B) Retropharyngeal cellulitis (arrowheads) in children with Kawasaki disease. (C, D) Retropharyngeal cellulitis (arrowheads) in children with deep neck infection. (E, F) Retropharyngeal abscess with rim enhancement (arrowheads) in children with deep neck infection. (G, H) Parapharyngeal abscess with rim enhancement (arrowheads) in children with deep neck infection.
Empirical antibiotics administered to children with deep neck infection
| Antibiotics | No. (%) |
|---|---|
| β-Lactam agent and clindamycin combination | 22 (61.1) |
| Amoxicillin/clavulanate+clindamycin | 13 (36.1) |
| 2nd or 3rd generation cephalosporin+clindamycin | 7 (19.4) |
| Amoxicillin/clavulanate+3rd generation cephalosporin+clindamycin | 2 (5.6) |
| β-Lactam agent | 14 (38.9) |
| Amoxicillin/clavulanate | 8 (22.2) |
| 2nd or 3rd generation cephalosporin | 6 (16.7) |